Nasdaq provides after market quotes of stock trades from 4:00 P.M. EST to 8:00 P.M. EST. After Hours participation from Market Makers and ECNs is strictly voluntary. Investors who anticipate ...

Nasdaq provides pre-market quotes of stock trades from 4:00 A.M. EST to 9:29 A.M. EST. After Hours participation from Market Makers and ECNs is strictly voluntary. Investors who anticipate trading ...

Vanguard Value Index Fund ETF Shares (NYSE:VTV) seeks to track the performance of the CRSP US Large Cap Value Index. This benchmark index focuses on investing in large-cap American stocks.

The High Point-based vTv Therapeutics Inc. has received a designation as a breakthrough therapy by the U.S. FDA for its TTP399 oral supplement that treats type 1 diabetes and psoriasis.

vTv Therapeutics Announces $51 Million Private Placement from Healthcare-focused Institutional Investors and the JDRF T1D Fund PRESS RELEASE GlobeNewswire Feb. 28, 2024, 08:00 AM ...

The video features the logos of Venezuela’s state-backed television station Venezolana de Televisión (VTV) and depicts a newscaster saying, “With the triumph of this Latin American leader on ...

Phase 1 multiple ascending dose study to evaluate safety of HPP737 in healthy volunteers and inform dose selection for phase 2 planned for 2H 2021 ...

vTv Therapeutics of High Point has out-licensed worldwide development and commercialization rights to its potential kidney disease drug to a California biotech company in a deal that ultimately ...

VTV is a cost-efficient, well-diversified large-cap value ETF that's tailor made for passive investors. Read why VTV is a top performer.

vTv Therapeutics (VTVT, Financials) surged 42.99% to $21.23 on Monday after the U.S. Food and Drug Administration lifted a clinical hold on thecompany's development program for cadisegliatin, an ...

vTv expects to use the proceeds from the PIPE to fund the first Phase 3 study of its lead product candidate, cadisegliatin, which is expected to initiate in mid-2024.